Infantile Hemangioma — Trials

Infantile Hemangioma — Trials · CancerIndex

Clinical trials

Registered studies

21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06677853	Timolol Maleate Gel for the Treatment of Infantile Hemangioma	completed	Phase 2 / Phase 3	168	Auson Pharmaceuticals Inc.INDUSTRY	1	Nov 7, 2024	clinicaltrials
NCT02913612	Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)(TIM01)	completed	Phase 2	105	Kanecia Obie ZimmermanOTHER	1	Mar 12, 2024	clinicaltrials
NCT01010308	Nadolol for Proliferating Infantile Hemangiomas	completed	Phase 2	20	The Hospital for Sick ChildrenOTHER	1	Aug 19, 2021	clinicaltrials
NCT01056341	Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy

Data updated 23 days agoSource updated Nov 7, 2024source: clinicaltrials